top of page
Profile
Join date: Jan 21, 2026
Posts (8)
Jun 12, 2026 ∙ 9 min
What U.S. Voters Really Think About Psychedelics: An Interview with the Co-Author of a New UC Berkeley Report
In May 2026, the UC Berkeley Center for the Science of Psychedelics published findings from its second UC Berkeley Psychedelics Survey, which tracks changes in U.S. voter perceptions of psychedelics. To explore what these findings reveal about changing public attitudes in the United States, Drug Science Head of Communications Hannah Barnett spoke with report co-author Tyrone J. Sgambati.
119
0
May 26, 2026 ∙ 4 min
What Sisyphus Can Teach Us About Psychiatric Drug Development
By Hannah Barnett A popular metaphor for futile and repetitive labour comes from Greek mythology, in which Zeus condemns King Sisyphus to eternally roll a massive boulder up a hill, only for it to tumble back down just before reaching the summit. In a new editorial published in the Journal of Psychopharmacology, David Nutt considers whether modern psychopharmacology has fallen into its own Sisyphean cycle through the relentless pursuit of highly specific psychiatric drugs. These drugs target...
190
0
Apr 30, 2026 ∙ 3 min
From Schedule I to III: What the U.S. Cannabis Rescheduling Really Changes
In late April, the Donald Trump administration announced plans to reschedule marijuana from a Schedule I to Schedule III substance.
328
0
bottom of page